+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interleukin-1 binding and prostaglandin E2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-alpha, transforming growth factor-beta, and interleukin-1 receptor antagonist



Interleukin-1 binding and prostaglandin E2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-alpha, transforming growth factor-beta, and interleukin-1 receptor antagonist



Biochimica et Biophysica Acta 1181(1): 31-36



Proinflammatory cytokines may promote preterm labor in the setting of intrauterine infection. Tumor necrosis factor (TNF) and interleukin-1 (IL-1) synergistically stimulate the production of prostaglandin E2 (PGE2) by amnion cells. Transforming growth factor-beta (TGF-beta) inhibits the cytokine-stimulated PGE2 production. In the present study, we investigated the binding of IL-1 beta on human amnion cells in culture. Untreated amnion cells possessed 540 +/- 60 IL-1 receptors per cell, with a dissociation constant of 1.4 +/- 0.4 nM. Cells treated with TGF-beta 1 (10 ng/ml) had 570 +/- 110 receptors per cell. TNF-alpha (50 ng/ml) increased the number of IL-1 receptors to 2930 +/- 590. TGF-beta 1 inhibited the receptor upregulation by TNF-alpha. Cells treated with TGF-beta 1 and TNF-alpha expressed 1140 +/- 590 receptors per cell. The binding affinity was not changed by the cytokines. IL-1 receptor antagonist (IL-1ra) inhibited the stimulation of amnion cell PGE2 production by IL-1 beta, but not by TNF-alpha. Amnion cells secreted large amounts of IL-1ra (1.1 +/- 0.3 ng/10(5) cells). Treatment of the cells with TGF-beta 1 or TNF-alpha did not affect the release of IL-1ra. We conclude that IL-1 receptor expression is an important step in the regulation of the effects of cytokines on amnion cell PGE2 production.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008898058

Download citation: RISBibTeXText

PMID: 8457602


Related references

Interleukin-1 binding and prostaglandin E2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-α, transforming growth factor-β, and interleukin-1 receptor antagonist. Biochimica et Biophysica Acta - Molecular Basis of Disease 1181(1): 31-36, 1993

Epidermal growth factor and transforming growth factor-alpha enhance the interleukin-1- and tumor necrosis factor-stimulated prostaglandin E2 production and the interleukin-1 specific binding on amnion cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids 49(6): 923-928, 1993

Epidermal growth factor and transforming growth factor-α enhance the interleukin-1- and tumor necrosis factor-stimulated prostaglandin E2 production and the interleukin-1 specific binding on amnion cells. Prostaglandins, Leukotrienes and Essential Fatty Acids 49(6): 923-928, 1993

Epidermal growth factor egf and transforming growth factor alpha tgf alpha synergize with interleukin 1 il 1 and tumor necrosis factor tnf in stimulating prostaglandin e2 pge2 production by amnion cells. Pediatric Research 31(4 Part 2): 39A, 1992

Transforming growth factor beta 2 differentially modulates interleukin 1 beta and tumor necrosis factor alpha stimulated phospholipase a 2 and prostaglandin e 2 synthesis in rat renal mesangial cells. Biochemical Journal 270(1): 269-272, 1990

Modulation of interleukin 1 il 1 receptor expression on amnion cells by tumor necrosis factor tnf and transforming growth factor beta tgf beta. Pediatric Research 31(4 Part 2): 197A, 1992

Transforming growth factor beta tgf beta opposes the stimulatory effects of interleukin 1 il 1 and tumor necrosis factor tnf on amnion cell prostaglandin e2 pge2 production implication for preterm labor. Pediatric Research 31(4 Part 2): 197A, 1992

Alternative splicing of human prostaglandin g h synthase mrna and evidence of differential regulation of the resulting transcripts by transforming growth factor beta 1 interleukin 1 beta and tumor necrosis factor alpha. Journal of Biological Chemistry 267(15): 10816-10822, 1992

Transforming growth factor-beta opposes the stimulatory effects of interleukin-1 and tumor necrosis factor on amnion cell prostaglandin E2 production: implication for preterm labor. American Journal of Obstetrics and Gynecology 167(1): 222-226, 1992

Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production. Alcoholism Clinical and Experimental Research 20(5): 900-907, 1996

Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra. Journal of Infectious Diseases 178(4): 1105-1114, 1998

Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells. American Journal of Obstetrics and Gynecology 170(4): 1194-1198, 1994

Regulation of prostaglandin secretion from epithelial and stromal cells of the bovine endometrium by interleukin-1 beta, interleukin-2, granulocyte-macrophage colony stimulating factor and tumor necrosis factor-alpha. Life Sciences 51(14): 1171-1176, 1992

Regulation of tumor necrosis factor-receptor type 1 and 2 shedding by interleukin-1, tumor necrosis factor, and transforming growth factor-beta in human articular chondrocytes. Arthritis & Rheumatism 42(9 Suppl. ): S190, 1999

Interleukin-4 and transforming growth factor-beta-1 oppose the stimulatory effects of interleukin-1 and tumor necrosis factor on decidual cell prostaglandin E-2 production. Pediatric Research 35(4 Part 2): 218A, 1994